A conjunctive coordination phrase-based analysis of Palestinian ‘or wh -word’ questions
Nota Bene · 12.11.2026 · 3 (2) · 291-307
DOI: 10.1075/nb.00059.kha ↗Kurz gefasst
Fachartikel in der Zeitschrift Nota Bene, online erschienen am 12.11.2026. Verfasst von Samir Khalaily. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
This paper argues that Palestinian alternative questions corresponding to the English ‘or wh-word’ questions (OWQs) such as Are you coming or what? have a more articulated structure than it is assumed (see Biezma and Rawlins 2017 ). It is grounded on the thesis that the Palestinian counterpart of “or” willa / walla ‘and-if-not’ in OWQs is a non-atomic primitive comprising the conjunctive coordinator AND, the conditional complementizer IF, and the negative operator NOT. Such a perspectival shift yields the conjunctive coordination phrase-based analysis of OWQs, where the coordination-head selects two semantic arguments: the polar question and the conditional question with a negative antecedent. Main evidence comes from morphosyntactic facts, ban on “yes and no” response, and focusing the NOT component part of willa / walla . If our account is correct, the syntax of focus-structure turns to be the Archimedian anchor for inquisitivity analysis (cf. a different view by Dayal 2025 ), contra the in-situ focus-interpretation approach championed by Rooth (1992) and his followers.
Zitieren
APA
Khalaily, S. (2026). A conjunctive coordination phrase-based analysis of Palestinian ‘or wh -word’ questions. Nota Bene, 3(2), 291-307. https://doi.org/10.1075/nb.00059.kha
Vancouver
Khalaily S. A conjunctive coordination phrase-based analysis of Palestinian ‘or wh -word’ questions. Nota Bene. 2026;3(2):291-307. doi:10.1075/nb.00059.kha
BibTeX
@article{Khalaily2026,
author = {Khalaily, Samir},
title = {A conjunctive coordination phrase-based analysis of Palestinian ‘or wh -word’ questions},
journal = {Nota Bene},
year = {2026},
volume = {3},
number = {2},
pages = {291--307},
doi = {10.1075/nb.00059.kha}
}
EUVIMED